HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Eyes Higher Impact With Shorter Ads Where Consumers Are Looking

This article was originally published in The Rose Sheet

Executive Summary

P&G’s Vicks brand will advertise year round since 40% of colds hit during times other than winter, P&G Chief Brand Officer Marc Pritchard says. The strategy also is part of the firm’s push to grow media reach for certain brands by as much as 20%.

You may also be interested in...



P&G Portfolio Rationalization Brushes Off 20% Of Oral Care SKUs

P&G completes the bulk of the portfolio rationalization it launched in 2014, shedding or restructuring more than half of its brands globally to focus on 10 core categories, says CFO Jon Moeller.

Oral Care Tops Colgate Priorities, Ad Spending Grows With Marketplace 'Uncertainty'

Colgate will boost its ad and promotional spend in 2017 “quite meaningfully” from 2016 to track with competitors' levels. "We focus in order of priority behind oral care, pet nutrition, personal care, and home care," says CEO Ian Cook.

Manufacturing, Advertising Coalition Tackles Digital Ad-Block Devastation

P&G and Unilever work with Google and advertising experts worldwide to form the Coalition for Better Ads aiming for new online advertising standards. The coalition has not yet determined whether Google would provide better placement for ads complying with the standards.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel